Androgen deprivation for prostate cancer: More than meets the eye

Presenter: Dr. Laurent Azoulay
Date: Tuesday, September 6, 2016

Join Dr. Azoulay to learn more about:
  • The unintended effects of androgen deprivation therapy in the treatment of prostate cancer
  • This presentation will include the findings of four important studies conducted by Dr. Azoulay’s research team 

Dr. Laurent Azoulay's Biography:

Dr. Laurent Azoulay is an Associate Professor in the Department of Epidemiology, Biostatistics, and Occupational Health and the Gerald Bronfman Department of Oncology at McGill University, and a Senior Investigator at the Centre for Clinical Epidemiology of the Lady Davis Institute of the Jewish General Hospital. His CIHR-funded research program focuses on the association between certain medications and the risk of cancer, as well as assessing the safety of cancer treatments. He has published numerous studies assessing the safety of androgen deprivation therapy, several of which were published in top-tier journals. 

Expert Angle
About Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.


Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.

Click here for news archive